K279-1004 Screening compound: 3-{5-[(2-{[4-(AMINOSULFONYL)PHENETHYL]AMINO}-2-OXOETHYL)SULFANYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL}-N~1~-CYCLOHEXYLPROPANAMIDE

K279-1004 Screening compound: 3-{5-[(2-{[4-(AMINOSULFONYL)PHENETHYL]AMINO}-2-OXOETHYL)SULFANYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL}-N~1~-CYCLOHEXYLPROPANAMIDE
K279-1004 Screening compound: 3-{5-[(2-{[4-(AMINOSULFONYL)PHENETHYL]AMINO}-2-OXOETHYL)SULFANYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL}-N~1~-CYCLOHEXYLPROPANAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-1004
3-{5-[(2-{[4-(AMINOSULFONYL)PHENETHYL]AMINO}-2-OXOETHYL)SULFANYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL}-N~1~-CYCLOHEXYLPROPANAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-1004

Molecular Formula

C29H34N6O5S2 (C29 H34 N6 O5 S2)

Compound Name

3-{5-[(2-{[4-(AMINOSULFONYL)PHENETHYL]AMINO}-2-OXOETHYL)SULFANYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL}-N~1~-CYCLOHEXYLPROPANAMIDE

IUPAC name

n/a

SMILES

NS(c1ccc(CCNC(CSC(N2C3CCC(NC4CCCCC4)=O)=Nc(cccc4)c4C2=NC3=O)=O)cc1)(=O)=O

InChI

InChI=1S/C29H34N6O5S2/c30-42(39,40)21-12-10-19(11-13-21)16-17-31-26(37)18-41-29-33-23-9-5-4-8-22(23)27-34-28(38)24(35(27)29)14-15-25(36)32-20-6-2-1-3-7-20/h4-5,8-13,20,24H,1-3,6-7,14-18H2,(H,31,37)(H,32,36)(H2,30,39,40)/t24-/m0/s1

InChI Key

WPOHPGMAGWRHHP-DEOSSOPVSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

610.76

Hydrogen Bond Acceptors Count

14.00

Hydrogen Bond Donors Count

4.00

Rotatable Bond Count

13.00

Number of Nitrogen and Oxygen Atoms

11

Partition Coefficient, logP

1.229

Distribution Coefficient, logD

1.228

Water Solubility, LogSw

-2.36

Polar Surface Area

134.265

Acid Dissociation Constant (pKa)

10.18

Base Dissociation Constant (pKb)

3.90

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

41.40

K279-1004 in Drug Discovery

Included in Screening Libraries

3CLpro Library (4801 compounds)

CORONAVIRUS Library (20774 compounds)

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with K279-1004 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-1004?
Check Price and Availability of K279-1004, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-1004 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-1004
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-1004
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-1004 available by request